Pricing Log in Create free account

NeuroSense Therapeutics Ltd. (NRSN) vs Windtree Therapeutics, Inc. (WINT)

NeuroSense Therapeutics Ltd. and Windtree Therapeutics, Inc. are both Biotechnology companies. NeuroSense Therapeutics Ltd. is the larger, with a market value of $2.6M against $2.4M — 1.1× the size. Across the 9 metrics below, Windtree Therapeutics, Inc. leads on 6 and NeuroSense Therapeutics Ltd. on 3.

Valuation

Metric NRSN WINT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 63.80 9.02
Earnings yield (832.79%) 0.00% (32.88%)
Free cash flow yield (909.43%) 0.00% (23.13%)

Profitability

Metric NRSN WINT Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 1,356.23% (51.96%)
Return on assets 0.00% (210.34%) (46.06%)
Return on invested capital 0.00% (386.34%) 0.00%

Growth

Metric NRSN WINT Biotechnology median
Revenue growth (TTM) — (68.35%) 6.76%
EPS growth (last fiscal year) 18.52% 97.79% 29.88%
Revenue growth, 5-year CAGR — (41.28%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRSN WINT Biotechnology median
Debt to equity 0.00 (1.48) 0.00
Current ratio 0.28 0.33 4.97
Net debt to EBITDA 0.01 0.03 1.01

Dividend

Metric NRSN WINT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NRSN WINT Biotechnology median
Market cap 2.64m 2.35m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack